We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.31B
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+18.36%
3 Year Est. Return
+53.76%
5 Year Est. Return
+60.8%
10 Year Est. Return
+204.74%
AUM
$1.12B
AUM Growth
+$112M
Cap. Flow
+$60M
Cap. Flow %
5.36%
Top 10 Hldgs %
18.63%
Holding
2,236
New
123
Increased
666
Reduced
418
Closed
73

Sector Composition

Rank Sector Weight
1 Energy 8.6%
2 Technology 7.13%
3 Industrials 7.08%
4 Consumer Staples 6.57%
5 Financials 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNCR
1776
DELISTED
Synchronoss Technologies
SNCR
$6K ﹤0.01%
84
-26
-24% -$2.51K
SRPT icon
1777
Sarepta Therapeutics
SRPT
$1.63B
$6K ﹤0.01%
118
TBF icon
1778
ProShares Short 20+ Year Treasury ETF
TBF
$85.7M
$6K ﹤0.01%
300
XHE icon
1779
State Street SPDR S&P Health Care Equipment ETF
XHE
$161M
$6K ﹤0.01%
105
-200
-66% -$12.9K
XTN icon
1780
State Street SPDR S&P Transportation ETF
XTN
$401M
$6K ﹤0.01%
99
VRN
1781
DELISTED
Veren
VRN
$6K ﹤0.01%
900
-200
-18% -$1.51K
NBIS
1782
Nebius Group N.V.
NBIS
$43.1B
$6K ﹤0.01%
200
XIFR
1783
XPLR Infrastructure LP
XIFR
$1.11B
$6K ﹤0.01%
+142
New +$5.71K
SAVE
1784
DELISTED
Spirit Airlines, Inc.
SAVE
$6K ﹤0.01%
135
MFD
1785
DELISTED
Macquarie/First Trust Global Infrastructure/Utilities Dividend & Income Fund
MFD
$6K ﹤0.01%
500
DCPH
1786
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$6K ﹤0.01%
+300
New +$5.88K
NVTA
1787
DELISTED
Invitae Corporation
NVTA
$6K ﹤0.01%
749
+224
+43% +$2.01K
ZYNE
1788
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$6K ﹤0.01%
500
NIB
1789
DELISTED
iPath Bloomberg Cocoa Subindex Total Return ETN due June 24, 2038
NIB
$6K ﹤0.01%
300
-400
-57% -$9.92K
RDUS
1790
DELISTED
Radius Health, Inc.
RDUS
$6K ﹤0.01%
200
CVA
1791
DELISTED
Covanta Holding Corporation
CVA
$6K ﹤0.01%
400
USCR
1792
DELISTED
U S Concrete, Inc.
USCR
$6K ﹤0.01%
76
AER icon
1793
AerCap
AER
$24.3B
$5K ﹤0.01%
100
ARKW icon
1794
ARK Web x.0 ETF
ARKW
$1.64B
$5K ﹤0.01%
125
BBU
1795
DELISTED
Brookfield Business Partners
BBU
$5K ﹤0.01%
249
+1
+0.4% +$20
CMRE icon
1796
Costamare
CMRE
$1.86B
$5K ﹤0.01%
900
CUBE icon
1797
CubeSmart
CUBE
$9.62B
$5K ﹤0.01%
205
DKS icon
1798
Dick's Sporting Goods
DKS
$18.9B
$5K ﹤0.01%
200
DNN icon
1799
Denison Mines
DNN
$2.49B
$5K ﹤0.01%
10,325
DVAX
1800
DELISTED
Dynavax Technologies
DVAX
$5K ﹤0.01%
295

Similar funds

Geneos Wealth Management's Q4 2017 Portfolio in Review

As of Q4 2017, Geneos Wealth Management held 2,236 positions worth $1.12B, up 11% from $1.01B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneos Wealth Management deployed $60M of net new capital in Q4 2017, opening 123 new positions and adding to 666 existing holdings. Its largest new stake was Highland Opportunities and Income Fund: 319,891 shares worth $4.72M.

By sector, the portfolio is most concentrated in Energy at 8.6% of assets, down from 9.1% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Vanguard Intermediate-Term Corporate Bond ETF, an estimated $6.21M trimmed.

  • Geneos Wealth Management's largest Q4 2017 buy was Highland Opportunities and Income Fund: 319,891 shares worth $4.72M.
  • Geneos Wealth Management added most to iShares TIPS Bond ETF in Q4 2017, an estimated $7.53M increase.
  • Geneos Wealth Management's biggest Q4 2017 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $6.21M.
  • Geneos Wealth Management fully exited iShares Currency Hedged MSCI Eurozone ETF in Q4 2017, selling an estimated $2.79M.
  • Geneos Wealth Management's ten largest holdings make up 19% of its $1.12B portfolio in Q4 2017.
  • Geneos Wealth Management opened 123 new positions and closed 73 in Q4 2017.
  • Geneos Wealth Management's portfolio value rose 11% quarter-over-quarter to $1.12B.

Based on Geneos Wealth Management's 13F filing for Q4 2017, filed 7 Sep 2021.